STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more

In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the drugs
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events